UgenTec Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
50

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
9
UgenTec General Information
Description
Developer of SaaS-based molecular diagnostics software intended for sample orchestration, result calling, quality control (QC) and lab intelligence. The company's software intelligently analyzes raw PCR data from multiple commercial devices, resulting in a more reliable measurement and enabling laboratories to automate and standardize their workflow.
Contact Information
Website
www.ugentec.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
- Kempische Steenweg 303/105
- 3500 Hasselt
- Belgium
+32 078 00 00 00
UgenTec Timeline
UgenTec Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
UgenTec Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of SaaS-based molecular diagnostics software intended for sample orchestration, result calling, quality contro
Other Healthcare Technology Systems
Hasselt, Belgium
50
As of 2022
000.00
000000000000
000.00
UgenTec Competitors (36)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Qlucore | Formerly VC-backed | Lund, Sweden | 00 | 000.00 | 00000000 | 000.00 |
000000 | Venture Capital-Backed | Providence, RI | 00 | 0000 | 00000000000 | 0000 |
000000 00000000 | Formerly VC-backed | Saint Sulpice, Switzerland | 000 | 00000 | 000000000 | 00000 |
00000 | Formerly VC-backed | Fremont, CA | 000 | 00000 | 00000000 | 00000 |
000000000 | Private Equity-Backed | Creve Coeur, MO | 000 | 000.00 | 000000000000 | 000.00 |
UgenTec Patents
UgenTec Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190026426-A1 | Methods for fluorescence data correction | Active | 11-Apr-2014 | ||
US-20170032083-A1 | Methods for fluorescence data correction | Inactive | 11-Apr-2014 | ||
EP-3129500-B1 | Methods for fluorescence data correction | Active | 11-Apr-2014 | 000000000 | |
EP-3129500-A1 | Methods for fluorescence data correction | Active | 11-Apr-2014 | 000000000 | |
EP-3916109-A1 | Methods for fluorescence data correction | Inactive | 11-Apr-2014 | G16B25/20 |
UgenTec Executive Team (6)
UgenTec Signals
UgenTec Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|